Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ryo Inose
The Factors Reducing Relative Dose Intensity of Cisplatin and Vinorelbine as Adjuvant Chemotherapy in Patients With Non-Small Cell Lung Cancer
Oncomedicine
Related publications
Feasibility and Efficacy of Adjuvant Chemotherapy With a Split-Dose Regimen of Cisplatin Plus Vinorelbine in Japanese Patients With Completely Resected Stage II-IIIA Non-Small Cell Lung Cancer -A Retrospective Analysis-
Japanese Journal of Lung Cancer
Oncology
Respiratory Medicine
Pulmonary
Triplet Chemotherapy Combination With Cisplatin, Gemcitabine and Docetaxel in Patients With Chemotherapy‑naive Advanced Non-Small Cell Lung Cancer
Oncology Letters
Cancer Research
Oncology
P2.16-45 Should Patients With Stage IB Non-Small Cell Lung Cancer Receive Adjuvant Chemotherapy?
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Maintaining Dose Intensity of Adjuvant Chemotherapy in Older Patients With Breast Cancer
Clinical Breast Cancer
Cancer Research
Oncology
Gemcitabine Plus Vinorelbine in Elderly or Unfit Patients With Non-Small Cell Lung Cancer
British Journal of Cancer
Cancer Research
Oncology
Factors Associated With Adherence to Chemotherapy Guidelines in Patients With Non-Small Cell Lung Cancer
Lung Cancer
Cancer Research
Oncology
Respiratory Medicine
Pulmonary
Refractory Non-Small-Cell Lung Cancer Responding to Combination Chemotherapy With Gemcitabine and Cisplatin
Japanese Journal of Lung Cancer
Oncology
Respiratory Medicine
Pulmonary
Effects of Chinese Medicine as Adjunct Medication for Adjuvant Chemotherapy Treatments of Non-Small Cell Lung Cancer Patients
Scientific Reports
Multidisciplinary
Oncologic Treatment of Non-Small Cell Lung Cancer Part B: Adjuvant Chemotherapy for Resected Non-Small Cell Lung Carcinoma
